Φορτώνει......
Reversible p53 inhibition prevents cisplatin ototoxicity without blocking chemotherapeutic efficacy
Cisplatin is a widely used chemotherapy drug, despite its significant ototoxic side effects. To date, the mechanism of cisplatin‐induced ototoxicity remains unclear, and hearing preservation during cisplatin‐based chemotherapy in patients is lacking. We found activation of the ATM‐Chk2‐p53 pathway t...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | EMBO Mol Med |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
John Wiley and Sons Inc.
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5210089/ https://ncbi.nlm.nih.gov/pubmed/27794029 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201606230 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|